Bladder Pain Syndrome: clinical trials and information
Bladder Pain Syndrome clinical trials in Canada
| Phase | Provinces | ||||
|---|---|---|---|---|---|
| Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome NCT02858453 | Unknown status | Phase 3 | British Columbia, Ontario, Quebec | Aquinox Pharmaceuticals (Canada) Inc. | 2016-07 |
Bladder Pain Syndrome clinical trials worldwide (outside Canada)
19 trials, 5 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Venlafaxine Combined With Education and Behavioral Intervention for Bladder Pain Syndrome NCT07698626 | Not yet recruiting | Phase 1 | Beijing Tiantan Hospital | 2026-12-31 | |
| Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis NCT04734106 | Recruiting | Early phase 1 | United States | Wake Forest University Health Sciences | 2025-02-18 |
| Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment NCT06299683 | Recruiting | Not applicable | United States | Vanderbilt University Medical Center | 2024-05-01 |
| Investigation of PEMF Therapy for Female Patients With IC/BPS NCT05149573 | Recruiting | Not applicable | United States | Wake Forest University Health Sciences | 2022-08-29 |
| EPPIC: Easing Pelvic Pain Interventions Clinical Research Program NCT05127616 | Recruiting | Not applicable | United States | State University of New York at Buffalo | 2022-08-10 |
| Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations NCT06013449 | Withdrawn | Not applicable | Wake Forest University Health Sciences | 2026-05 | |
| Auricular Acupressure Therapy for Patients With IC/BPS NCT05857020 | Withdrawn | Not applicable | Wake Forest University Health Sciences | 2024-07 | |
| A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain NCT05658874 | Terminated | Phase 3 | United States | Jocelyn Fitzgerald | 2022-12-06 |
| Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms NCT05276466 | Unknown status | Not applicable | United States | MicroGenDX | 2022-02-01 |
| Biopsychosocial and Conventional Approach in Bladder Pain Syndrome NCT05155384 | Unknown status | Not applicable | Turkey (Türkiye) | Hacettepe University | 2021-11-12 |
| Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome NCT04734847 | Active, not recruiting | Not applicable | United States | University of Southern California | 2021-06-01 |
| PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome NCT04540887 | Completed | Not applicable | United States | Wake Forest University Health Sciences | 2021-02-24 |
| The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary SymptOms in INterstitial Cystitis (CHRONIC) NCT04349930 | Withdrawn | Phase 1 | United States | University of New Mexico | 2021-01 |
| Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome NCT04275297 | Completed | Not applicable | United States | Vanderbilt University Medical Center | 2020-07-13 |
| Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome NCT04789135 | Unknown status | Phase 2 | Brazil | Anhembi Morumbi University | 2020-03-20 |
| Translational Research in Pelvic Pain NCT04001244 | Completed | Portugal, United Kingdom | University of Oxford | 2019-09-01 | |
| Intravesical Injection of Dextrose to Improve Lower Urinary Tract Symptoms Caused by Chronic Cystitis NCT04821882 | Completed | Not applicable | Taiwan | National Defense Medical Center, Taiwan | 2019-05-01 |
| Microbiome of Urologic Chronic Pelvic Pain Syndrome NCT03027076 | Withdrawn | United States | Johns Hopkins University | 2013-11 | |
| Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study NCT01879930 | Terminated | Phase 4 | Switzerland | Insel Gruppe AG, University Hospital Bern | 2012-11 |
About Bladder Pain Syndrome
What is Bladder Pain Syndrome?
Chronic pelvic pain is pain in the lower abdomen or pelvis that lasts six months or longer. It can be linked to gynecological, urological, gastrointestinal or musculoskeletal conditions, and more than one factor may be involved.
How is Bladder Pain Syndrome usually assessed?
Assessment often includes a detailed history, physical and pelvic examination, and tests or imaging chosen to look for specific causes.
What kinds of treatments are studied for Bladder Pain Syndrome?
Registered studies cover medicines, medical devices (such as nerve stimulators), procedures (such as nerve blocks or injections), physical and movement therapies, psychological approaches (such as cognitive behavioural therapy), education programs and digital tools. Being studied in a trial does not mean a treatment works or is approved. The interventions listed on this page come directly from the registry records.
How can I find Bladder Pain Syndrome clinical trials in Canada?
This page lists 1 registry record for this term with at least one site in Canada, recruiting studies first. Each trial page links to the official ClinicalTrials.gov record, which lists the study contacts. Recruiting status changes often, so check the registry, and talk to your doctor before joining a study.
Related conditions
Related interventions
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.